IVIEW-1201

DRUG3 trials

Sponsors

IVIEW Therapeutics Inc.

Conditions

Acute Bacterial ConjunctivitisAdenoviral ConjunctivitisFungal Keratitis

Phase 2

Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis

CompletedNCT03749317

IVIEW Therapeutics Inc.Adenoviral Conjunctivitis

Start: 2023-02-20End: 2024-12-31Updated: 2025-10-15

Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Bacterial Conjunctivitis

CompletedNCT05816070

IVIEW Therapeutics Inc.Acute Bacterial Conjunctivitis

Start: 2023-01-05End: 2024-10-12Updated: 2025-12-02

Trial to Evaluate the Efficacy And Safety of IVIEW-1201 In the Treatment of Fungal Keratitis

Not yet recruitingNCT06463678

IVIEW Therapeutics Inc.Fungal Keratitis

Start: 2026-08-01End: 2027-12-31Target: 60Updated: 2025-10-15